Technical Analysis for ACRS - Aclaris Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 6.46 -6.51% -0.45
ACRS closed down 6.51 percent on Wednesday, January 16, 2019, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ACRS trend table...

Date Alert Name Type % Chg
Jan 16 Oversold Stochastic Weakness 0.00%
Jan 15 Doji - Bullish? Reversal -6.51%
Jan 15 Stochastic Reached Oversold Weakness -6.51%
Jan 15 Oversold Stochastic Weakness -6.51%
Jan 14 20 DMA Resistance Bearish -5.83%
Jan 14 180 Bearish Setup Bearish Swing Setup -5.83%
Jan 14 Outside Day Range Expansion -5.83%
Jan 14 Down 3 Days in a Row Weakness -5.83%
Jan 14 Down 4 Days in a Row Weakness -5.83%
Jan 14 Down 5 Days in a Row Weakness -5.83%

Older signals for ACRS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Is ACRS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.89
52 Week Low 6.15
Average Volume 607,000
200-Day Moving Average 14.8752
50-Day Moving Average 8.3823
20-Day Moving Average 7.1425
10-Day Moving Average 7.248
Average True Range 0.4796
ADX 37.17
+DI 13.0101
-DI 30.709
Chandelier Exit (Long, 3 ATRs ) 6.7512
Chandelier Exit (Short, 3 ATRs ) 7.5888
Upper Bollinger Band 7.9293
Lower Bollinger Band 6.3557
Percent B (%b) 0.07
BandWidth 22.031502
MACD Line -0.4113
MACD Signal Line -0.4339
MACD Histogram 0.0226
Fundamentals Value
Market Cap 172.71 Million
Num Shares 26.7 Million
EPS -2.03
Price-to-Earnings (P/E) Ratio -3.18
Price-to-Sales 0.00
Price-to-Book 3.83
PEG Ratio -0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.25
Resistance 3 (R3) 7.32 7.13 7.12
Resistance 2 (R2) 7.13 6.93 7.09 7.07
Resistance 1 (R1) 6.80 6.81 6.70 6.72 7.03
Pivot Point 6.61 6.61 6.56 6.57 6.61
Support 1 (S1) 6.27 6.40 6.18 6.20 5.89
Support 2 (S2) 6.08 6.28 6.04 5.85
Support 3 (S3) 5.75 6.08 5.80
Support 4 (S4) 5.67